The central government plans to partner with international pharmaceutical companies to build a Covid-19 vaccine research center in Bali.
Through the Coordinator of Maritime and Investment Minister Luhut Binsar Pandjaitan, the central government confirmed that Indonesia plans to build a Covid-19 vaccine research center in Bali.
This will be done in cooperation with international pharmaceutical companies such as Pfizer, Merck, and Cansino, in the hopes of empowering Indonesian scientists to develop a Covid vaccine.
“We plan to build a Covid-19 vaccine research center in cooperation with Merck, Pfizer, and Cansino,” Luhut said on Saturday (29/1).
He also stated that Indonesia is preparing to mass-produce a Covid-19 vaccine called Merah Putih Vaccine. It will be fully developed by Indonesian scientists by June 2022.
Luhut revealed that there are many talented Indonesians working in the medical, pharmaceutical, and epidemiology fields who haven’t been adequately empowered by the government.
“After personally handling this pandemic, I realized that we have many experts in Indonesia. However, most of us think that we’re still inferior to expats,” Luhut concluded.
Plan Your Next Bali Vacation:
Book The Best English Speaking Drivers For Airport Transfers & Tours
Choose From Thousands of Bali Hotels, Resorts, and Hostels with Free Cancellation On Most Properties
For the latest Bali News & Debate Join our Facebook Community
SUBSCRIBE TO NEW POSTS
Enter your email address to subscribe to The Bali Sun’s latest breaking news, straight to your inbox.